medigraphic.com
ISSN 0016-3813 (Print)

2003, Number s4

<< Back Next >>

Gac Med Mex 2003; 139 (s4)

New Human Papilloma Viruses Discovered in Mexico: Their Association with High Incidence of Cancer of the Cervix.

Berumen-Campos J

Language: Spanish
References: 26
Page: 3-10
PDF size: 126.34 Kb.


Text Extraction

No abstract


REFERENCES

  1. Muñoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N. et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 1992;52:743-9.

  2. Muñoz N, Bosch FX. Cervical cancer and human papillomavirus: Epidemiological evicence and presepectives for prevention. Salud Publica Mex 1997;39:274-282.

  3. Gissman L, zur Hausen H. Partial characterization of viral DNA from human genital warts (Condylomata acuminata). Int. J. Cancer 1980;25:605-9.

  4. Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H. Molecular cloning and characterization of human papillomavirus DNA derived from a laryngeal papilloma. J. Virol 1982;44:393-400.

  5. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA 1983;80:3812-5.

  6. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its prevalence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 1984;3:1151-7.

  7. Nindl I, Benítez-Bribiesca L, Berumen J, Farmanara N, Fisher S, Gross G, López-Carrillo L, Muller M, Tommasino M, Vázquez-Curiel A, Gissmann L. “Antibodies against linear and conformational epitopes of the human papillomavirus (HPV) type 16 E6 and E7 oncoproteins in sera of cervical cancer patients”. Archives of Virology 1994;137:341-353.

  8. Cullen AP, Reid R, Campion M, And Lörincz AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J.Virol 1991;65:606-612.

  9. Choo KB, Pan CC, Han SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161:259-261.

  10. Wilczynski SP, Pearlman L, Walker J. Identification of HPV16 early genes retained in cervical carcinomas. Virology 1988;166:624-627.

  11. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (London) 1985;314:111-114.

  12. Schneider-Manoury S, Croissant O, Orth G. Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors. J. Virol. 1987;61:3295-3298.

  13. Berumen J, Casas L, Segura E, Amezcua JL, García-Carrancá A. “Genome amplification of Human Papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes”. International Journal of Cancer 1994;56:640-645.

  14. Berumen J, Unger ER, Casas L, Figueroa P. “Amplification of Human Papillomavirus types 16 and 18 in invasive cervical cancer”. Human Pathology 1995;26:676-681.

  15. Yamada T, Wheeler CM, Halpern AL, Stewart ACM, Hildesheim A, Jenison SA. Human-papillomavirus-type-16-variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J. Virol. 1995;69:7743-7753.

  16. Yamada T, Manos MM, Peto J, Greer CE, Muñoz N, Bosch FX, Wheelers C. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. Journal of Virolgy 1997;71:2463-72.

  17. Casas L, Galván SC, Ordoñez RM, López N, Guido M, Berumen J. “Asian-American variants of Human Papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas”. International Journal of Cancer 1999;83:449-455.

  18. Berumen J, Ordóñez RM, Salmeron J, Lazcano E, Galvan S, Estrada RA, Yunes E, García-Carrancá A, Gonzalez-Lira G, Madrigal-De La Campa. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. Journal of the National Cancer Institute 2001;93:1325-1330.

  19. Stoppler M, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70;6987-6993:1996.

  20. Veress G, Szarka K, Dong X, Gergely L, Pfister H. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J. Gen. Virol 80;1035-1043:1999.

  21. Kammer C, Warthorst U, Torrez-Martínez N, Wheeler CM, Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J. Gen. Virol 81;1975-1981:2000.

  22. Ordóñez RM, Armendáriz-Borunda J, Berumen J. Enhanced oncogenicity of Asian-American Human Papillomavirus 16 is associated with impaired E2 repression of E6/E7-oncogens transcription. Cancer Research, enviado a publicación (2002).

  23. Lazcano E, Nájera P, Alonso P, Buiatti E, Hernández-Avila M. Programa de detección oportuna del cáncer cervical en México. I. Diagnóstico situacional. Rev. Inst. Nal. Cancerología 1996;42:123-40.

  24. Registro Histopatológico de Neoplasias en México. Dirección General de Epidemiología, Secretaria de Salud, México D.F. , México, 1997.

  25. Dillner J., Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. Int. J. Cancer 1990;46:703-711.

  26. Kónya J, Eklund C, Geijersstam V, Yuan F, Stuber G, Dillner J. Identification of a cytotoxic-T-lymphocyte epitope in the human- papillomavirus-type-16 E2 protein. J. Gen. Virol 1997;78:2615-2620.




2020     |     www.medigraphic.com